$297.69
+5.53 (+1.89%)
At Close: Jun 09, 2026
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
A Top Contender in the Race for a NASH Drug Drops Out
03:02pm, Thursday, 23'rd Jul 2020
French biotech Genfit, which had been expected to bring one of the first drugs to market to treat nonalcoholic steatohepatitis, said it is getting out of the race altogether.
Alnylam to Webcast Conference Call Discussing Second Quarter 2020 Financial Results
12:00pm, Thursday, 23'rd Jul 2020
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2020 on Thursday, Augu
Alnylam’s Anant Murthy on making it as a US biotech in Europe -
09:50am, Monday, 20'th Jul 2020
Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the many unique challenges of the EU market
SQZ Biotech Appoints Paul Bolno, MD to Board of Directors and Kai Wucherpfennig, MD, PhD to Scientific Advisory Board
12:00am, Monday, 20'th Jul 2020
SQZ Biotechnologies (SQZ), a clinical stage cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appoi
Morgan Stanley Increases Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $199.00
05:36am, Sunday, 19'th Jul 2020
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target increased by Morgan Stanley from $162.00 to $199.00 in a research report sent to investors on Wednesday, BenzingaRatingsTable reports. They c
Fauci says U.S. needs to 'get better control' of the coronavirus to reopen without outbreaks
05:43pm, Friday, 17'th Jul 2020
Dr. Anthony Fauci said Friday that the coronavirus has hit the U.S. "very severely" and the country "needs to get better control over things" in order to reopen the economy and head toward normality.
Steroid's COVID-19 benefits confirmed; spotlight on immune cells
12:00am, Friday, 17'th Jul 2020
Steroid's COVID-19 benefits confirmed; spotlight on immune cells
IFM Investors Pty Ltd Sells 2,193 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
06:02pm, Thursday, 16'th Jul 2020
IFM Investors Pty Ltd lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) by 20.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exc
Alnylam (ALNY) Upgraded to Buy: Here's Why
04:00pm, Tuesday, 14'th Jul 2020
Alnylam (ALNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
WSJ News Exclusive | Oat-Milk Company Oatly Draws Investment From Blackstone-Led Group Including Oprah
04:30am, Tuesday, 14'th Jul 2020
Swedish oat-milk maker Oatly has sold a $200 million stake to a group led by private-equity giant Blackstone Group that includes Oprah Winfrey, Natalie Portman, former Starbucks Chief Howard Schultz a
Alnylam Pharmaceuticals (NASDAQ:ALNY) Trading Down 5.9% After Insider Selling
01:18am, Tuesday, 14'th Jul 2020
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)’s share price dropped 5.9% during mid-day trading on Monday after an insider sold shares in the company. The company traded as low as $152.01 and last tra
The Global Biodefense Market will grow by USD 3.22 bn during 2020-2024
The number of confirmed cases of the coronavirus illness COVID-19 worldwide edged closer to 13 million on Monday, a day after the World Health Organization...
Sign In
Buy ALNY